UNDERSTAND YOUR OPTIONS
Cancer imaging & treatment, by diagnosis.
The right scan or therapy depends on your cancer type, prior treatment, and the question your care team needs to answer.
Start with your cancer type.
IMAGING
Prostate cancer
PSMA PET/CT
PSMA PET/CT can help evaluate prostate cancer in appropriate clinical settings. The tracer, clinical question, and referral determine whether it is suitable.
IMAGING
Breast cancer
FES PET/CT
FES PET evaluates estrogen receptor–positive lesions in recurrent or metastatic breast cancer as an adjunct to biopsy. It does not replace a biopsy when one is indicated.
IMAGING & TREATMENT INFORMATION
Thyroid cancer
Thyroid imaging & radioactive iodine
Thyroid cancer imaging is owner-listed. Radioactive iodine is a treatment option for selected iodine-avid differentiated cancers, including papillary and follicular thyroid cancer.
TREATMENT INFORMATION
Neuroendocrine tumors
Lutathera
Lutathera is used for somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors: cancers arising in the gastrointestinal tract or pancreas. It is not a treatment for every neuroendocrine tumor.
Imaging is used to evaluate disease. Treatment is intended to act on it. An imaging referral does not mean that a targeted treatment is appropriate or currently available.
FDG PET/CT for other cancers
FDG PET/CT is used in oncology for selected clinical questions. For example, it may help assess lung cancer or lymphoma. The usefulness of a scan varies by cancer type and situation; an abnormal scan is not, by itself, a cancer diagnosis.
Learn more: PET/CT: RadiologyInfo (ACR/RSNA)
Examples: lung cancer imaging and lymphoma imaging (ACR/RSNA).
Learn about FDG PET/CTTargeted therapies are cancer-specific.
Prostate cancer
Pluvicto is a targeted radioactive treatment for eligible patients with PSMA-positive metastatic prostate cancer.
Explore this serviceNeuroendocrine tumors
Lutathera is a receptor-targeted treatment for eligible gastroenteropancreatic neuroendocrine tumors.
Explore this serviceThyroid cancer
Radioactive iodine may be considered for selected papillary and follicular thyroid cancers that take up iodine.
Explore this serviceContact Fusion to confirm current treatment availability and the records needed for specialist review. These pages explain treatment options; they do not confirm eligibility or an available treatment appointment.
Let’s help you take the next step.
Call our Las Vegas team to discuss the requested study, a referral, or a cost estimate.
Call (702) 720-4392